miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression

(2010) Yasunori Fujita et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression

(2010) Ming Zhou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma

(2010) Guichun Huang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells

(2010) N. Patel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

(2009) D. R. Cochrane et al.   MOLECULAR CANCER THERAPEUTICS

Mechanisms of adaptive angiogenesis to tissue hypoxia

(2008) Guo-Hua Fong   ANGIOGENESIS

Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5

(2008) J. Shi et al.   CANCER RESEARCH

Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer

(2008) R. Nagel et al.   CANCER RESEARCH

Role of microRNAs in drug-resistant ovarian cancer cells

(2008) Antonio Sorrentino et al.   GYNECOLOGIC ONCOLOGY

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

(2008) Lin Xia et al.   INTERNATIONAL JOURNAL OF CANCER

MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer

(2008) T. Oguri et al.   MOLECULAR CANCER THERAPEUTICS

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

(2008) O. Kovalchuk et al.   MOLECULAR CANCER THERAPEUTICS

The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice

(2008) Neri Mercatelli et al.   PLoS One